Net delta exposure for Regeneron Pharmaceuticals Inc (REGN) options was $954.1M per 1% move at the Nov 4, 2026 close. It has been positive on 20 of the last 20 trading days. Four weeks earlier, on Oct 7, 2026, it was $137.93M.
Upgrade to unlock Call Wall, Put Wall, and multiple expiration dates.
Delta Exposure by Strike
Showing results for REGN, 2026-11-06(w), calls & puts
Delta Exposure Stats
Showing results for REGN, 2026-11-06(w), calls & puts
Net Delta Exposure by Expiration
Showing results for REGN, 2026-11-06(w), calls & puts. View all expiries
| Expiration | Net DEX | Call DEX | Put DEX | Call Wall | Put Wall |
|---|
REGN Delta Exposure FAQ
What is delta exposure (DEX)?
Delta exposure estimates the dollar value of shares option dealers hold or owe as a hedge, per 1% move in the underlying.
Is REGN delta exposure positive or negative?
Regeneron Pharmaceuticals net delta exposure was positive on Nov 4, 2026, at $954.1M. It has been positive on 20 of the last 20 trading days.
How has REGN delta exposure changed recently?
Regeneron Pharmaceuticals net delta exposure went from $137.93M on Oct 7, 2026 to $954.1M on Nov 4, 2026. See the REGN delta exposure history for a longer view.
What is Regeneron Pharmaceuticals Inc?
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation.